Albemarle Corp buy Wells Fargo & Company
Start price
18.07.23
/
50%
€212.40
Target price
18.07.24
€240.30
Performance (%)
-59.23%
End price
19.07.24
€86.60
Summary
This prediction ended on 19.07.24 with a price of €86.60. The BUY prediction by Wells_Fargo___Compan for Albemarle Corp performed very badly with a performance of -59.23%. Wells_Fargo___Compan has a follow-up prediction for Albemarle Corp where he still thinks Albemarle Corp is a Buy. Dividends of €1.48 are taken into consideration when calculating the performance. Wells_Fargo___Compan has 50% into this predictionAlbemarle is a specialty chemical company that produces and markets lithium, bromine, and other specialty chemicals globally. The company's products are used in a wide range of applications, including energy storage, flame retardants, pharmaceuticals, and agricultural solutions. Albemarle's lithium business has been a key driver of growth in recent years due to increasing demand for lithium-ion batteries used in electric vehicles and other technologies. The company has a market capitalization of around $11 billion and is listed on the New York Stock Exchange under the ticker symbol ALB.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Albemarle Corp | -3.542% | -3.542% | -55.992% |
| iShares Core DAX® | -0.612% | 0.567% | 12.585% |
| iShares Nasdaq 100 | -3.018% | -3.205% | 26.208% |
| iShares Nikkei 225® | -2.647% | 0.330% | 9.482% |
| iShares S&P 500 | -1.932% | -1.126% | 23.191% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Albemarle Corp diskutieren
Albemarle Co. (NYSE: ALB) had its price target raised by analysts at Wells Fargo & Company from $250.00 to $270.00. They now have an "overweight" rating on the stock.
Ratings data for ALB provided by MarketBeat
In the thread Trading Albemarle Corp
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten